LINDSEY GREENE: Open Payments
NPI 1962804450 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 36 payments from 12 companies in 2025. Trend: 2023 $76 · 2024 $609 · 2025 $601
Food & beverage: $601
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 16 | $209 |
| Vanda Pharmaceuticals Inc. | 2 | $75 |
| Almatica Pharma LLC | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Tris Pharma Inc | 2 | $37 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Neos Therapeutics, LP | 2 | $35 |
| Corium, LLC | 4 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
Products named: REXULTI, FANAPT, LOREEV XR, Auvelity, Dyanavel XR, Jornay PM, Adzenys XR-ODT, Azstarys.
Industry payments across AZ — which companies pay providers there.
